Navigation Links
Immune system's bare essentials used to speedily detect drug targets
Date:10/31/2010

Scientists at Johns Hopkins have taken a less-is-more approach to designing effective drug treatments that are precisely tailored to disease-causing pathogens, such as viruses and bacteria, and cancer cells, any of which can trigger the body's immune system defenses.

In a report to be published in the latest issue of Nature Medicine online Oct. 31, researchers describe a new "epitope-mapping" laboratory test that within three weeks can pinpoint the unique binding site or epitope from any antigen where immune system T cells can most securely attach and attack invading germs or errant cells.

Knowing exactly where the best antigen-T-cell fit occurs at sites where short stretches of proteins, called peptides, bind and are displayed on the surface of antigen-processing immune system cells is a prerequisite for designing effective and targeted drug therapies, researchers say.

Identifying the best binding site, they say, should speed up cancer vaccine development, lead to new diagnostic tests that detect the first appearance of cancer cells, well before tumors develop, and sort out disorders that are difficult to diagnose, such as Lyme disease.

"Our new, simplified system reproduces what happens in the cells of the immune system when antigens from a pathogen first enter the body and need to be broken down into peptides to become visible to T cells, one of the two immune defender cell types," says immunologist Scheherazade Sadegh-Nasseri, Ph.D., an associate professor of pathology, biophysics and biophysical chemistry at the Johns Hopkins University School of Medicine. "Once T cells recognize an antigen, they latch on, become activated, and call for other immune system cells to enter the fight," adds Sadegh-Nasseri, the senior study investigator for the team of scientists who developed the new epitope-mapping process.

Sadegh-Nasseri says the team's new lab test takes a fraction of the time involved in current
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Certain cancer therapies success depends on presence of immune cell, Stanford study shows in mice
2. Mount Sinai researchers discover origin of immune cells in the brain
3. Virginia Bioinformatics Institute to model immune responses to gut pathogens
4. Cell survival protein discovery rewrites immune system story
5. Melanoma uses bodys immune system to spread to lungs
6. Air pollution alters immune function, worsens asthma symptoms
7. OHSU research reveals possible method for boosting the immune system to protect infants against HIV
8. Immune System Genes Show Links to Type 1 Diabetes
9. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
10. Scientists discover the mechanisms and function of a type of mysterious immune cell
11. Researchers closer to development of drug to prevent deadly immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Living in a quality ... that comes along with it. A quality Home Owners ... such amenities are available. , Simpson ... Georgia and Community Association Management, LLC made a recent ... Company to provide an additional amenity for their neighborhood. ...
(Date:8/21/2014)... arteries of chronic kidney disease patients may be a ... new study in the Journal of the American ... the Johns Hopkins Bloomberg School of Public Health assert ... of subclinical atherosclerosis in predicting the risk of heart ... percent of all patients with chronic kidney disease (CKD) ...
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... August 21, 2014 The City of ... for entertainment and programming for its inaugural “Re:Imagine Garden ... October 12, 2014, from 11 a.m. to 4 p.m., ... all cars and the downtown will be filled with ... by Community Arts Resources (CARS), for all to enjoy. ...
(Date:8/21/2014)... Among seniors, dimming vision may be tied to poorer survival, ... people, aged 65 to 84, who were assessed when they ... years later. Vision loss over time was associated with ... study period, the researchers reported. Although the study couldn,t ... Purdue University in West Lafayette, Ind., offered up some theories ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... new study by Ohio State University researchers has shown ... are not being managed appropriately.,The researchers who looked at ... patients' own descriptions of anxiety after a heart attack ... doctors do not match. In the group of,participants it ...
... been found for detecting upper urinary tract transitional cell ... Canada. This method checks for fibrinogen/fibrin degradation products. It ... to standard urinary cytology. The Researchers compared the efficacy ... cytology in establishing the diagnosis// of transitional cell carcinoma ...
... came up in 1971 argued that people react to ... eventually return to a stable level of well-being. Researchers ... France and England confirmed this theory based on a ... on life satisfaction. 24,000 individuals were followed for 15 ...
... first of its kind study compared a group of whiplash patients ... who suffered a whiplash injury had pain in the neck, head, ... a year. In the study of the two groups, pain in ... a month while in the whiplash injury group patients were still ...
... Examination Survey has now uncovered a link between Periodontal ... of gum disease that causes infection and inflammation of ... of the study where divided into two groups, depending ... an indicator of the presence of periodontal disease. They ...
... Live cancer is one of the most aggressive cancers worldwide ... countries due to hepatitis infection and aflatoxin contamination of foodstuffs. ... Researchers in the US and China have been studying gene ... and found a way of detecting tumors that spread. They ...
Cached Medicine News:
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... HPQ - Free Report ), IBM (NYSE: IBM ... - Free Report ), GlaxoSmithKline plc (NYSE: GSK - ... - Free Report ). Today, Zacks is promoting ...
Breaking Medicine Technology:eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... Inc., a privately-held developer and marketer of the VerifyNow ... for measuring platelet reactivity to multiple antiplatelet agents, announced ... Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow ... The VerifyNow System is widely used by practicing ...
... SUNNYVALE, Calif., March 2, 2011 Pharmacyclics, Inc. (Nasdaq: ... of PCI-45292, a Btk inhibitor with exceptionally potent anti-arthritis ... results from the current set of preclinical toxicology studies. ... candidate identified within approximately 6 months. ...
Cached Medicine Technology:Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2Update on Preclinical Finding and Development Timeline for PCI-45292 2Update on Preclinical Finding and Development Timeline for PCI-45292 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 7.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Medicine Products: